U.S. pharma giant copyright scrapped two experimental weight loss capsules very last calendar year—a as soon as-each day pill, lotiglipron, because of elevated liver enzymes in addition to a twice-everyday tablet, danuglipron, resulting from solid Unwanted effects—but CEO Albert Bourla has claimed the company is determined to “play and acquir